Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    18515185 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: Rotigotine

Study has passed its completion date and status has not been verified in more than two years.